Atlas Trials

Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

Clinical trial NCT06629363 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06629363
Sponsor
Centre Hospitalier de PAU
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Malignant Hypertension
Start date
2025-08-01
Primary completion
2036-04-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.